Hims Stock Crashes 33% After Novo Ends Wegovy Deal

5 articles I'm watching carefully

In partnership with

Tyler Dupont
logo

Good morning 👋

Here's the latest news I'm tracking today.

 📈 Stocks / Finance

Hims Stock Crashes 33% After Novo Ends Wegovy Deal

Hims stock fell over 33% after Novo Nordisk terminated their weight-loss drug partnership, citing 'deceptive promotion' of compounded Wegovy alternatives. Novo alleged illegal sales practices, while Hims defended personalized dosing. Novo shares dropped 6%.

Oil Volatility Emerges as Key Market Driver

Oil futures fell ~6% Monday, with Brent below $72.50 and WTI near $70, after reports of Iranian missile strikes. Stocks rose in response. Strategists warn a spike to ~$120 could trigger inflation and hit equities. Iran’s potential Strait of Hormuz closure remains a key risk.

Trump Media Approves $400M Buyback Despite Heavy Losses

Trump Media authorized a $400M stock buyback, citing $3B in balance sheet assets. The buyback won’t affect its $2.5B bitcoin treasury plan. Despite a $400.9M loss on $3.6M revenue in 2024, the firm holds $776.8M in cash and a $4.9B market cap.

🪙 Crypto

XRP Mining Unveils Cloud Contracts for Passive Crypto Yield

XRP Mining launched a cloud mining program allowing users to stake assets like BTC, ETH, and DOGE in short-term contracts with daily profit payouts. No hardware is required, and withdrawals begin at $100. The firm claims over 5M global users.

🌎 Global Economy

IMF Cautions U.S.–Iran Strikes Could Hit Global Growth

The IMF warned U.S. strikes on Iran could disrupt energy supplies and amplify economic uncertainty. Brent crude briefly rose 5.7% to $81.40. The IMF cited possible 'secondary and tertiary impacts' on growth, noting already lowered global forecasts.

Hands Down Some Of The Best 0% Interest Credit Cards

Pay no interest until nearly 2027 with some of the best hand-picked credit cards this year. They are perfect for anyone looking to pay down their debt, and not add to it!

Click here to see what all of the hype is about.

Did you like today's newsletter?
Powered by Typeform